🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
92.49
+0.54 (0.59%)
At close: Nov 18, 2026, 4:00 PM EST
92.60
+0.11 (0.12%)
After-hours: Nov 18, 2026, 4:32 PM EST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Livmarli Revenue
482.36M360.01M213.30M
Bile Acid Medicines Revenue
188.42M161.31M123.11M
Total Product Revenue, Net
670.78M521.31M336.41M
License and Other Revenue
--479.00K
Revenue (Total)
670.78M521.31M336.89M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
License and Other Revenue
--479.00K
United States - Product Revenue
532.27M401.55M274.17M
Rest of the World - Product Revenue
138.51M119.77M62.24M
Revenue (Total)
670.78M521.31M336.89M